New research is giving scientists a better understanding of the processes in the body that can lead to cancer.

Iterion Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing the treatment of Wnt-driven cancers, ...

Largest cellular study of gut tissue unveils the genes and pathways driving inflammatory bowel disease, suggesting new therapeutic targets.

Growing momentum for RAS inhibition at ASCO highlights Namodenoson’s RAS pathway inhibition and encouraging data in ...

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel ...

In March 2026, Boehringer Ingelheim achieved a research milestone under the agreement for SZN-413, reflecting a positive outcome of the IND-enabling GLP toxicology study. The Company received a $5.0 ...

Good morning, and welcome to the Equillium Virtual Investor Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Equillium website ...

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.

By: Eunice Jean C. Patron Biological processes like the Wnt signaling pathway—which regulates crucial development and helps keep the body’s tissues functioning normally and in balance—are often ...

Cancer immunotherapy has entered a transformative era, providing durable benefits to many patients. However, a substantial subset of malignancies remains ...

BACKGROUND: Bisphenol F (BPF) is a common substitute for bisphenol A and the most prevalent bisphenol compound in diverse ...